Streetbeat News

Equity Actions

SYT

SYLA Technologies Co., Ltd. (NASDAQ:SYT) has initiated its Employee Stock Purchase Plan (ESPP), which has started purchasing the company's American Depositary Shares (ADSs) on the NASDAQ market. The ESPP was established in August 2023 to enhance the welfare of SYLA employees and promote asset building by providing incentives for employees to acquire and hold the company's shares.

Portfolio Pulse from Happy Mohamed

October 19, 2023 | 8:12 pm

DMK

FUV

DMK Pharmaceuticals Corporation (NASDAQ:DMK) has announced a series of management changes, including the appointment of Seth Cohen as Chief Financial Officer and John Dorbin as General Counsel Corporate Secretary. The changes are aimed at optimizing the company's leadership structure, increasing sales of existing products, and advancing its clinical pipeline. Both Cohen and Dorbin bring extensive experience in their respective fields. Cohen has over thirty years of experience in business and finance, while Dorbin has over two decades of experience representing publicly traded companies and serving as an independent business consultant.

Portfolio Pulse from Happy Mohamed

October 19, 2023 | 8:12 pm

LAKE

Lakeland Industries announced that Charles Roberson will step down as President, CEO, and member of the Board effective Jan. 31, 2024. Current Executive Chairman, James M. Jenkins, will oversee the Company's Executive Management Team.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 8:11 pm

ARQT

Arcutis Biotherapeutics, Inc. has announced a proposed public offering of $100 million. The company plans to use the net proceeds from the offering for general corporate purposes.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 8:10 pm

WDFC

WD-40 Company has provided its fiscal year 2024 guidance, projecting net sales growth between 6% and 12%, with net sales expected to be between $570M and $600M on a non-GAAP constant currency basis. The company's estimated EPS for FY24 is $4.78-$5.15, lower than the estimated $5.30. Unanticipated inflationary headwinds and other unforeseen events may further affect the company's financial results.

Portfolio Pulse from Happy Mohamed

October 19, 2023 | 8:08 pm

MCBC

Macatawa Bank Corp. and Macatawa Bank announced a leadership transition with Ronald L. Haan retiring as president and CEO on November 1, 2023. Jon Swets, who has been with the bank since 2002, will take over as president and CEO, while Bryan Barker will become the chief financial officer. Haan will continue to serve on the board until May 2024 and will remain engaged with community relations and customer development.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 8:05 pm

GILD

IKNA

Gilead Sciences has reported a 6.7% stake in Ikena Oncology, according to a 13G filing with the SEC.

Portfolio Pulse from Benzinga Newsdesk

October 19, 2023 | 7:38 pm

NNDM

Nano Dimension Ltd (NASDAQ:NNDM) has received court approval for its $200 million share repurchase plan. The company is now authorized to repurchase stock in open market transactions, privately negotiated transactions, or through other legal methods. The buyback plan does not obligate Nano Dimension to repurchase any specific number of shares. The company's shares were up 9.27% at $2.71 at the time of publication.

Portfolio Pulse from Adam Eckert

October 19, 2023 | 7:35 pm

CHDN

CMCSA

COIN

EA

SOLUSD

Third Time Entertainment, the company behind the blockchain-based virtual horse racing game Photo Finish LIVE, has closed a new $2 million seed+ funding round. The round was led by Sfermion and included investments from Reciprocal Ventures, Big Brain Holdings, 32-Bit Ventures, and 6th Man Ventures. This follows a previous seed funding round of $3.5 million in March 2022, which included investments from London Venture Partners and Coinbase Global Inc. The new funds will be used to expand the company's product offering, add team members, and explore strategic partnerships.

Portfolio Pulse from Chris Katje

October 19, 2023 | 7:34 pm

TAK

Takeda Pharmaceutical Inc.'s (NYSE:TAK) shares are currently trading at $14.54, after a 0.65% drop. Despite a decrease of 8.76% over the past month, the stock has increased by 14.63% over the past year. The company's P/E ratio is 22.86, lower than the pharmaceutical industry's aggregate P/E ratio of 31.81, which could indicate that the stock is undervalued or has weak growth prospects.

Portfolio Pulse from Benzinga Insights

October 19, 2023 | 7:00 pm